Pfizer has entered into a series of agreements with Aurobindo Pharma Ltd., an India-based pharmaceutical company, to commercialize generics in the U.S. and Europe. “We will dramatically change Pfizer’s Established Products portfolio to an engine of positive growth. These agreements represent solid, measurable progress, and a strong commitment to achieve our growth objectives,” said David Simmons, president and general manager of Pfizer’s Established Products Business Unit. Pfizer’s Establish...